{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:45:29Z","timestamp":1788187529323,"version":"build-2803163510"},"publisher-location":"Singapore","reference-count":128,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789811915918","type":"print"},{"value":"9789811915925","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-981-19-1592-5_5","type":"book-chapter","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:03:09Z","timestamp":1652677389000},"page":"63-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["HDL and Oxidation"],"prefix":"10.1007","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongzhe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS et al (2016) Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13:48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124","journal-title":"Nat Rev Cardiol"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/jci118345","volume":"96","author":"BJ Van Lenten","year":"1995","unstructured":"Van Lenten BJ et al (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758\u20132767. https:\/\/doi.org\/10.1172\/jci118345","journal-title":"J Clin Invest"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/hc0302.103711","volume":"105","author":"M Navab","year":"2002","unstructured":"Navab M et al (2002) Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105:290\u2013292. https:\/\/doi.org\/10.1161\/hc0302.103711","journal-title":"Circulation"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","volume":"286","author":"MI Mackness","year":"1991","unstructured":"Mackness MI, Arrol S, Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152\u2013154. https:\/\/doi.org\/10.1016\/0014-5793(91)80962-3","journal-title":"FEBS Lett"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","volume":"8","author":"F Brites","year":"2017","unstructured":"Brites F, Martin M, Guillas I, Kontush A (2017) Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit. BBA Clin 8:66\u201377. https:\/\/doi.org\/10.1016\/j.bbacli.2017.07.002","journal-title":"BBA Clin"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/01.atv.21.4.473","volume":"21","author":"PN Durrington","year":"2001","unstructured":"Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473\u2013480. https:\/\/doi.org\/10.1161\/01.atv.21.4.473","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","volume":"41","author":"M Navab","year":"2000","unstructured":"Navab M et al (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41:1481\u20131494","journal-title":"J Lipid Res"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1021\/jf020095j","volume":"50","author":"CD Nuchi","year":"2002","unstructured":"Nuchi CD, Hernandez P, McClements DJ, Decker EA (2002) Ability of lipid hydroperoxides to partition into surfactant micelles and alter lipid oxidation rates in emulsions. J Agric Food Chem 50:5445\u20135449. https:\/\/doi.org\/10.1021\/jf020095j","journal-title":"J Agric Food Chem"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-319-09665-0_5","volume":"224","author":"H Karlsson","year":"2015","unstructured":"Karlsson H, Kontush A, James RW (2015) Functionality of HDL: antioxidation and detoxifying effects. Handb Exp Pharmacol 224:207\u2013228. https:\/\/doi.org\/10.1007\/978-3-319-09665-0_5","journal-title":"Handb Exp Pharmacol"},{"issue":"Pt 3","key":"5_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1042\/bj3140739","volume":"314","author":"J Christison","year":"1996","unstructured":"Christison J, Karjalainen A, Brauman J, Bygrave F, Stocker R (1996) Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochem J 314(Pt 3):739\u2013742. https:\/\/doi.org\/10.1042\/bj3140739","journal-title":"Biochem J"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1023\/a:1010203930470","volume":"66","author":"AN Klimov","year":"2001","unstructured":"Klimov AN, Kozhevnikova KA, Kuzmin AA, Kuznetsov AS, Belova EV (2001) On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes. Biochemistry (Mosc) 66:300\u2013304. https:\/\/doi.org\/10.1023\/a:1010203930470","journal-title":"Biochemistry (Mosc)"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbalip.2003.10.005","volume":"1635","author":"G Ferretti","year":"2003","unstructured":"Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G (2003) Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim Biophys Acta 1635:48\u201354. https:\/\/doi.org\/10.1016\/j.bbalip.2003.10.005","journal-title":"Biochim Biophys Acta"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/bbrc.2001.6150","volume":"290","author":"Z Ahmed","year":"2002","unstructured":"Ahmed Z et al (2002) Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite. Biochem Biophys Res Commun 290:391\u2013396. https:\/\/doi.org\/10.1006\/bbrc.2001.6150","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.abb.2006.04.010","volume":"451","author":"SD Nguyen","year":"2006","unstructured":"Nguyen SD, Jeong TS, Sok DE (2006) Apolipoprotein A-I-mimetic peptides with antioxidant actions. Arch Biochem Biophys 451:34\u201342. https:\/\/doi.org\/10.1016\/j.abb.2006.04.010","journal-title":"Arch Biochem Biophys"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1046\/j.1432-1327.2001.02253.x","volume":"268","author":"C Bergt","year":"2001","unstructured":"Bergt C et al (2001) Human neutrophils employ the myeloperoxidase\/hydrogen peroxide\/chloride system to oxidatively damage apolipoprotein A-I. Eur J Biochem 268:3523\u20133531. https:\/\/doi.org\/10.1046\/j.1432-1327.2001.02253.x","journal-title":"Eur J Biochem"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/atvbaha.109.194555","volume":"29","author":"A Zerrad-Saadi","year":"2009","unstructured":"Zerrad-Saadi A et al (2009) HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 29:2169\u20132175. https:\/\/doi.org\/10.1161\/atvbaha.109.194555","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1194\/jlr.R012658","volume":"52","author":"D Bashtovyy","year":"2011","unstructured":"Bashtovyy D, Jones MK, Anantharamaiah GM, Segrest JP (2011) Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function. J Lipid Res 52:435\u2013450. https:\/\/doi.org\/10.1194\/jlr.R012658","journal-title":"J Lipid Res"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"J Barter Philip","year":"2004","unstructured":"Barter Philip J et al (2004) Antiinflammatory properties of HDL. Circ Res 95:764\u2013772. https:\/\/doi.org\/10.1161\/01.RES.0000146094.59640.13","journal-title":"Circ Res"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.RES.0000146031.94850.5f","volume":"95","author":"V Ribas","year":"2004","unstructured":"Ribas V et al (2004) Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res 95:789\u2013797. https:\/\/doi.org\/10.1161\/01.RES.0000146031.94850.5f","journal-title":"Circ Res"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.atv.21.6.1023","volume":"21","author":"MA Ostos","year":"2001","unstructured":"Ostos MA et al (2001) Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1023\u20131028. https:\/\/doi.org\/10.1161\/01.atv.21.6.1023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1021\/bi9013227","volume":"49","author":"L Gaidukov","year":"2010","unstructured":"Gaidukov L et al (2010) ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Biochemistry 49:532\u2013538. https:\/\/doi.org\/10.1021\/bi9013227","journal-title":"Biochemistry"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","volume":"221","author":"S Elsoe","year":"2012","unstructured":"Elsoe S et al (2012) Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis 221:91\u201397. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.031","journal-title":"Atherosclerosis"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/atvbaha.109.186031","volume":"29","author":"WS Davidson","year":"2009","unstructured":"Davidson WS et al (2009) Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 29:870\u2013876. https:\/\/doi.org\/10.1161\/atvbaha.109.186031","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chemphyslip.2008.06.003","volume":"155","author":"LS Kumpula","year":"2008","unstructured":"Kumpula LS et al (2008) Reconsideration of hydrophobic lipid distributions in lipoprotein particles. Chem Phys Lipids 155:57\u201362. https:\/\/doi.org\/10.1016\/j.chemphyslip.2008.06.003","journal-title":"Chem Phys Lipids"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","volume":"21","author":"A Kontush","year":"2010","unstructured":"Kontush A, Chapman MJ (2010) Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol 21:312\u2013318. https:\/\/doi.org\/10.1097\/MOL.0b013e32833bcdc1","journal-title":"Curr Opin Lipidol"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cvr\/cvu147","volume":"103","author":"A Kontush","year":"2014","unstructured":"Kontush A (2014) HDL-mediated mechanisms of protection in cardiovascular disease. Cardiovasc Res 103:341\u2013349. https:\/\/doi.org\/10.1093\/cvr\/cvu147","journal-title":"Cardiovasc Res"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1373\/clinchem.2007.101923","volume":"54","author":"R Movva","year":"2008","unstructured":"Movva R, Rader DJ (2008) Laboratory assessment of HDL heterogeneity and function. Clin Chem 54:788\u2013800. https:\/\/doi.org\/10.1373\/clinchem.2007.101923","journal-title":"Clin Chem"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1172\/jci18004","volume":"113","author":"JR Nofer","year":"2004","unstructured":"Nofer JR et al (2004) HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569\u2013581. https:\/\/doi.org\/10.1172\/jci18004","journal-title":"J Clin Invest"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/89986","volume":"7","author":"IS Yuhanna","year":"2001","unstructured":"Yuhanna IS et al (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7:853\u2013857. https:\/\/doi.org\/10.1038\/89986","journal-title":"Nat Med"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1172\/jci35470","volume":"118","author":"N Terasaka","year":"2008","unstructured":"Terasaka N et al (2008) ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118:3701\u20133713. https:\/\/doi.org\/10.1172\/jci35470","journal-title":"J Clin Invest"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1161\/01.cir.103.18.2283","volume":"103","author":"BJ Van Lenten","year":"2001","unstructured":"Van Lenten BJ et al (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 103:2283\u20132288. https:\/\/doi.org\/10.1161\/01.cir.103.18.2283","journal-title":"Circulation"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.plipres.2012.03.003","volume":"51","author":"A Otocka-Kmiecik","year":"2012","unstructured":"Otocka-Kmiecik A et al (2012) Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res 51:314\u2013324. https:\/\/doi.org\/10.1016\/j.plipres.2012.03.003","journal-title":"Prog Lipid Res"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1073\/pnas.88.15.6457","volume":"88","author":"Y Nagano","year":"1991","unstructured":"Nagano Y, Arai H, Kita T (1991) High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci U S A 88:6457\u20136461. https:\/\/doi.org\/10.1073\/pnas.88.15.6457","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/atvbaha.108.179226","volume":"30","author":"JD Smith","year":"2010","unstructured":"Smith JD (2010) Dysfunctional HDL as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol 30:151\u2013155. https:\/\/doi.org\/10.1161\/atvbaha.108.179226","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nm.3459","volume":"20","author":"Y Huang","year":"2014","unstructured":"Huang Y et al (2014) An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med 20:193\u2013203. https:\/\/doi.org\/10.1038\/nm.3459","journal-title":"Nat Med"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/jci117342","volume":"94","author":"A Daugherty","year":"1994","unstructured":"Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437\u2013444. https:\/\/doi.org\/10.1172\/jci117342","journal-title":"J Clin Invest"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1172\/jci119379","volume":"99","author":"SL Hazen","year":"1997","unstructured":"Hazen SL, Heinecke JW (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99:2075\u20132081. https:\/\/doi.org\/10.1172\/jci119379","journal-title":"J Clin Invest"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0014-5793(99)00677-8","volume":"452","author":"C Bergt","year":"1999","unstructured":"Bergt C, Reicher H, Malle E, Sattler W (1999) Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages. FEBS Lett 452:295\u2013300. https:\/\/doi.org\/10.1016\/s0014-5793(99)00677-8","journal-title":"FEBS Lett"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"19536","DOI":"10.1074\/jbc.M000458200","volume":"275","author":"U Panzenbock","year":"2000","unstructured":"Panzenbock U, Kritharides L, Raftery M, Rye KA, Stocker R (2000) Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J Biol Chem 275:19536\u201319544. https:\/\/doi.org\/10.1074\/jbc.M000458200","journal-title":"J Biol Chem"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1073\/pnas.0802025105","volume":"105","author":"B Shao","year":"2008","unstructured":"Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW (2008) Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A 105:12224\u201312229. https:\/\/doi.org\/10.1073\/pnas.0802025105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"29711","DOI":"10.1074\/jbc.272.47.29711","volume":"272","author":"U Panzenboeck","year":"1997","unstructured":"Panzenboeck U et al (1997) Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem 272:29711\u201329720. https:\/\/doi.org\/10.1074\/jbc.272.47.29711","journal-title":"J Biol Chem"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1172\/jci21109","volume":"114","author":"L Zheng","year":"2004","unstructured":"Zheng L et al (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114:529\u2013541. https:\/\/doi.org\/10.1172\/jci21109","journal-title":"J Clin Invest"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nsmb1284","volume":"14","author":"Z Wu","year":"2007","unstructured":"Wu Z et al (2007) The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat Struct Mol Biol 14:861\u2013868. https:\/\/doi.org\/10.1038\/nsmb1284","journal-title":"Nat Struct Mol Biol"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"13032","DOI":"10.1073\/pnas.0405292101","volume":"101","author":"C Bergt","year":"2004","unstructured":"Bergt C et al (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 101:13032\u201313037. https:\/\/doi.org\/10.1073\/pnas.0405292101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"42977","DOI":"10.1074\/jbc.M406762200","volume":"279","author":"S Pennathur","year":"2004","unstructured":"Pennathur S et al (2004) Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 279:42977\u201342983. https:\/\/doi.org\/10.1074\/jbc.M406762200","journal-title":"J Biol Chem"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa035003","volume":"349","author":"ML Brennan","year":"2003","unstructured":"Brennan ML et al (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595\u20131604. https:\/\/doi.org\/10.1056\/NEJMoa035003","journal-title":"N Engl J Med"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/atvbaha.108.173815","volume":"28","author":"DQ Peng","year":"2008","unstructured":"Peng DQ et al (2008) Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function. Arterioscler Thromb Vasc Biol 28:2063\u20132070. https:\/\/doi.org\/10.1161\/atvbaha.108.173815","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"33775","DOI":"10.1074\/jbc.M504092200","volume":"280","author":"DQ Peng","year":"2005","unstructured":"Peng DQ et al (2005) Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities. J Biol Chem 280:33775\u201333784. https:\/\/doi.org\/10.1074\/jbc.M504092200","journal-title":"J Biol Chem"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","volume":"180","author":"CE Furlong","year":"1989","unstructured":"Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase\/arylesterase. Anal Biochem 180:242\u2013247. https:\/\/doi.org\/10.1016\/0003-2697(89)90424-7","journal-title":"Anal Biochem"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/circresaha.108.192229","volume":"104","author":"ZG She","year":"2009","unstructured":"She ZG et al (2009) Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res 104:1160\u20131168. https:\/\/doi.org\/10.1161\/circresaha.108.192229","journal-title":"Circ Res"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/atvbaha.112.253930","volume":"32","author":"WH Tang","year":"2012","unstructured":"Tang WH et al (2012) Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 32:2803\u20132812. https:\/\/doi.org\/10.1161\/atvbaha.112.253930","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","volume":"299","author":"T Bhattacharyya","year":"2008","unstructured":"Bhattacharyya T et al (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299:1265\u20131276. https:\/\/doi.org\/10.1001\/jama.299.11.1265","journal-title":"JAMA"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/jci1649","volume":"101","author":"M Aviram","year":"1998","unstructured":"Aviram M et al (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581\u20131590. https:\/\/doi.org\/10.1172\/jci1649","journal-title":"J Clin Invest"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2004.10.010","volume":"38","author":"PW Connelly","year":"2005","unstructured":"Connelly PW, Draganov D, Maguire GF (2005) Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. Free Radic Biol Med 38:164\u2013174. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.10.010","journal-title":"Free Radic Biol Med"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1194\/jlr.M400213-JLR200","volume":"45","author":"JF Teiber","year":"2004","unstructured":"Teiber JF, Draganov DI, La Du B, N. (2004) Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH. J Lipid Res 45:2260\u20132268. https:\/\/doi.org\/10.1194\/jlr.M400213-JLR200","journal-title":"J Lipid Res"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1074\/jbc.M211126200","volume":"278","author":"GK Marathe","year":"2003","unstructured":"Marathe GK, Zimmerman GA, McIntyre TM (2003) Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 278:3937\u20133947. https:\/\/doi.org\/10.1074\/jbc.M211126200","journal-title":"J Biol Chem"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1021\/bi047440d","volume":"44","author":"O Khersonsky","year":"2005","unstructured":"Khersonsky O, Tawfik DS (2005) Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry 44:6371\u20136382. https:\/\/doi.org\/10.1021\/bi047440d","journal-title":"Biochemistry"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/biof.188","volume":"37","author":"M Rosenblat","year":"2011","unstructured":"Rosenblat M, Volkova N, Aviram M (2011) Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. Biofactors 37:462\u2013467. https:\/\/doi.org\/10.1002\/biof.188","journal-title":"Biofactors"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1172\/jci67478","volume":"123","author":"Y Huang","year":"2013","unstructured":"Huang Y et al (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123:3815\u20133828. https:\/\/doi.org\/10.1172\/jci67478","journal-title":"J Clin Invest"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0009-8981(99)00106-0","volume":"286","author":"M Dobiasova","year":"1999","unstructured":"Dobiasova M, Frohlich JJ (1999) Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. Clin Chim Acta 286:257\u2013271. https:\/\/doi.org\/10.1016\/s0009-8981(99)00106-0","journal-title":"Clin Chim Acta"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.freeradbiomed.2007.08.007","volume":"43","author":"PA McPherson","year":"2007","unstructured":"McPherson PA, Young IS, McEneny J (2007) A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation. Free Radic Biol Med 43:1484\u20131493. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.08.007","journal-title":"Free Radic Biol Med"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/atvbaha.112.255711","volume":"32","author":"AG Holleboom","year":"2012","unstructured":"Holleboom AG et al (2012) Lipid oxidation in carriers of lecithin: cholesterol acyltransferase gene mutations. Arterioscler Thromb Vasc Biol 32:3066\u20133075. https:\/\/doi.org\/10.1161\/atvbaha.112.255711","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/7766","volume":"21","author":"M Jaye","year":"1999","unstructured":"Jaye M et al (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21:424\u2013428. https:\/\/doi.org\/10.1038\/7766","journal-title":"Nat Genet"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1074\/jbc.M807683200","volume":"284","author":"N Nijstad","year":"2009","unstructured":"Nijstad N et al (2009) Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase. J Biol Chem 284:6093\u20136100. https:\/\/doi.org\/10.1074\/jbc.M807683200","journal-title":"J Biol Chem"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/bj20031882","volume":"382","author":"M Gauster","year":"2004","unstructured":"Gauster M et al (2004) Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux. Biochem J 382:75\u201382. https:\/\/doi.org\/10.1042\/bj20031882","journal-title":"Biochem J"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1194\/jlr.M500054-JLR200","volume":"46","author":"M Gauster","year":"2005","unstructured":"Gauster M et al (2005) Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 46:1517\u20131525. https:\/\/doi.org\/10.1194\/jlr.M500054-JLR200","journal-title":"J Lipid Res"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbalip.2013.01.003","volume":"1831","author":"JC Escola-Gil","year":"2013","unstructured":"Escola-Gil JC et al (2013) Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties. Biochim Biophys Acta 1831:691\u2013697. https:\/\/doi.org\/10.1016\/j.bbalip.2013.01.003","journal-title":"Biochim Biophys Acta"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbalip.2019.06.011","volume":"1864","author":"I Schilcher","year":"2019","unstructured":"Schilcher I et al (2019) Endothelial lipase increases antioxidative capacity of high-density lipoprotein. Biochim Biophys Acta Mol Cell Biol Lipids 1864:1363\u20131374. https:\/\/doi.org\/10.1016\/j.bbalip.2019.06.011","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1161\/circulationaha.110.936393","volume":"122","author":"Z Mallat","year":"2010","unstructured":"Mallat Z, Lambeau G, Tedgui A (2010) Lipoprotein-associated and secreted phospholipases a(2) in cardiovascular disease: roles as biological effectors and biomarkers. Circulation 122:2183\u20132200. https:\/\/doi.org\/10.1161\/circulationaha.110.936393","journal-title":"Circulation"},{"issue":"Suppl","key":"5_CR70","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1194\/jlr.R800024-JLR200","volume":"50","author":"TM McIntyre","year":"2009","unstructured":"McIntyre TM, Prescott SM, Stafforini DM (2009) The emerging roles of PAF acetylhydrolase. J Lipid Res 50(Suppl):S255\u2013S259. https:\/\/doi.org\/10.1194\/jlr.R800024-JLR200","journal-title":"J Lipid Res"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/01.atv.15.10.1764","volume":"15","author":"AD Tselepis","year":"1995","unstructured":"Tselepis AD, Dentan C, Karabina SA, Chapman MJ, Ninio E (1995) PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler Thromb Vasc Biol 15:1764\u20131773. https:\/\/doi.org\/10.1161\/01.atv.15.10.1764","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11745-013-3779-1","volume":"48","author":"M Kotosai","year":"2013","unstructured":"Kotosai M et al (2013) Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability. Lipids 48:569\u2013578. https:\/\/doi.org\/10.1007\/s11745-013-3779-1","journal-title":"Lipids"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/0264-6021:3540001","volume":"354","author":"L Rodrigo","year":"2001","unstructured":"Rodrigo L, Mackness B, Durrington PN, Hernandez A, Mackness MI (2001) Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem J 354:1\u20137. https:\/\/doi.org\/10.1042\/0264-6021:3540001","journal-title":"Biochem J"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bbalip.2006.06.017","volume":"1761","author":"K Karasawa","year":"2006","unstructured":"Karasawa K (2006) Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 1761:1359\u20131372. https:\/\/doi.org\/10.1016\/j.bbalip.2006.06.017","journal-title":"Biochim Biophys Acta"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.4049\/jimmunol.181.4.2821","volume":"181","author":"A Pirillo","year":"2008","unstructured":"Pirillo A, Uboldi P, Bolego C, Kuhn H, Catapano AL (2008) The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells. J Immunol (Baltimore, Md. : 1950) 181:2821\u20132830. https:\/\/doi.org\/10.4049\/jimmunol.181.4.2821","journal-title":"J Immunol (Baltimore, Md. : 1950)"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/circresaha.108.193169","volume":"104","author":"G Marsche","year":"2009","unstructured":"Marsche G et al (2009) Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 104:750\u2013757. https:\/\/doi.org\/10.1161\/circresaha.108.193169","journal-title":"Circ Res"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/iub.508","volume":"63","author":"D Hine","year":"2011","unstructured":"Hine D, Mackness B, Mackness M (2011) Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation. IUBMB Life 63:772\u2013774. https:\/\/doi.org\/10.1002\/iub.508","journal-title":"IUBMB Life"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00041433-200406000-00004","volume":"15","author":"JJ Albers","year":"2004","unstructured":"Albers JJ, Cheung MC (2004) Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism. Curr Opin Lipidol 15:255\u2013260. https:\/\/doi.org\/10.1097\/00041433-200406000-00004","journal-title":"Curr Opin Lipidol"},{"key":"5_CR79","doi-asserted-by":"publisher","unstructured":"Sato M et al (2016) Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. Biosci Rep 36. https:\/\/doi.org\/10.1042\/bsr20160075","DOI":"10.1042\/bsr20160075"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/gt.2010.11","volume":"17","author":"C Zhang","year":"2010","unstructured":"Zhang C et al (2010) Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice. Gene Ther 17:626\u2013633. https:\/\/doi.org\/10.1038\/gt.2010.11","journal-title":"Gene Ther"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381\u20131478. https:\/\/doi.org\/10.1152\/physrev.00047.2003","journal-title":"Physiol Rev"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1161\/circresaha.114.303454","volume":"114","author":"B Shao","year":"2014","unstructured":"Shao B et al (2014) Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase. Circ Res 114:1733\u20131742. https:\/\/doi.org\/10.1161\/circresaha.114.303454","journal-title":"Circ Res"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1050-1738(01)00101-3","volume":"11","author":"JP Gaut","year":"2001","unstructured":"Gaut JP, Heinecke JW (2001) Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc Med 11:103\u2013112. https:\/\/doi.org\/10.1016\/s1050-1738(01)00101-3","journal-title":"Trends Cardiovasc Med"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1172\/jci12617","volume":"108","author":"S Baldus","year":"2001","unstructured":"Baldus S et al (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108:1759\u20131770. https:\/\/doi.org\/10.1172\/jci12617","journal-title":"J Clin Invest"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1074\/jbc.M411484200","volume":"280","author":"B Shao","year":"2005","unstructured":"Shao B et al (2005) Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 280:5983\u20135993. https:\/\/doi.org\/10.1074\/jbc.M411484200","journal-title":"J Biol Chem"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1074\/jbc.M309046200","volume":"279","author":"C Bergt","year":"2004","unstructured":"Bergt C, Fu X, Huq NP, Kao J, Heinecke JW (2004) Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 279:7856\u20137866. https:\/\/doi.org\/10.1074\/jbc.M309046200","journal-title":"J Biol Chem"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1210\/jc.2004-0305","volume":"89","author":"B Hansel","year":"2004","unstructured":"Hansel B et al (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89:4963\u20134971. https:\/\/doi.org\/10.1210\/jc.2004-0305","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","volume":"48","author":"E Nobecourt","year":"2005","unstructured":"Nobecourt E et al (2005) Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia 48:529\u2013538. https:\/\/doi.org\/10.1007\/s00125-004-1655-5","journal-title":"Diabetologia"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","volume":"197","author":"JA de Souza","year":"2008","unstructured":"de Souza JA et al (2008) Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 197:84\u201394. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.08.009","journal-title":"Atherosclerosis"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbalip.2016.10.014","volume":"1862","author":"L Gomez Rosso","year":"2017","unstructured":"Gomez Rosso L et al (2017) Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c. Biochim Biophys Acta Mol Cell Biol Lipids 1862:188\u2013195. https:\/\/doi.org\/10.1016\/j.bbalip.2016.10.014","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2337\/dc18-0049","volume":"41","author":"AV Mathew","year":"2018","unstructured":"Mathew AV et al (2018) Therapeutic lifestyle changes improve HDL function by inhibiting myeloperoxidase-mediated oxidation in patients with metabolic syndrome. Diabetes Care 41:2431\u20132437. https:\/\/doi.org\/10.2337\/dc18-0049","journal-title":"Diabetes Care"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2005.03.001","volume":"182","author":"A Kontush","year":"2005","unstructured":"Kontush A, de Faria EC, Chantepie S, Chapman MJ (2005) A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182:277\u2013285. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.03.001","journal-title":"Atherosclerosis"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.Atv.0000118276.87061.00","volume":"24","author":"A Kontush","year":"2004","unstructured":"Kontush A, de Faria EC, Chantepie S, Chapman MJ (2004) Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties. Arterioscler Thromb Vasc Biol 24:526\u2013533. https:\/\/doi.org\/10.1161\/01.Atv.0000118276.87061.00","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt A","key":"5_CR94","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","volume":"72","author":"DA Hottman","year":"2014","unstructured":"Hottman DA, Chernick D, Cheng S, Wang Z, Li L (2014) HDL and cognition in neurodegenerative disorders. Neurobiol Dis 72(Pt A):22\u201336. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.015","journal-title":"Neurobiol Dis"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","volume":"285","author":"I Lefterov","year":"2010","unstructured":"Lefterov I et al (2010) Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1DeltaE9 mice. J Biol Chem 285:36945\u201336957. https:\/\/doi.org\/10.1074\/jbc.M110.127738","journal-title":"J Biol Chem"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","volume":"285","author":"TL Lewis","year":"2010","unstructured":"Lewis TL et al (2010) Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. J Biol Chem 285:36958\u201336968. https:\/\/doi.org\/10.1074\/jbc.M110.127829","journal-title":"J Biol Chem"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000323265","volume":"8","author":"K Ikeda","year":"2011","unstructured":"Ikeda K et al (2011) Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression. Neurodegener Dis 8:252\u2013258. https:\/\/doi.org\/10.1159\/000323265","journal-title":"Neurodegener Dis"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0022-510x(01)00439-7","volume":"184","author":"SN Akhmedova","year":"2001","unstructured":"Akhmedova SN, Yakimovsky AK, Schwartz EI (2001) Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease. J Neurol Sci 184:179\u2013182. https:\/\/doi.org\/10.1016\/s0022-510x(01)00439-7","journal-title":"J Neurol Sci"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s10038-004-0176-x","volume":"49","author":"E Zintzaras","year":"2004","unstructured":"Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49:474\u2013481. https:\/\/doi.org\/10.1007\/s10038-004-0176-x","journal-title":"J Hum Genet"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1212\/01.wnl.0000324997.21272.0c","volume":"71","author":"PN Valdmanis","year":"2008","unstructured":"Valdmanis PN et al (2008) Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology 71:514\u2013520. https:\/\/doi.org\/10.1212\/01.wnl.0000324997.21272.0c","journal-title":"Neurology"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1212\/01.wnl.0000227187.52002.88","volume":"67","author":"M Saeed","year":"2006","unstructured":"Saeed M et al (2006) Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 67:771\u2013776. https:\/\/doi.org\/10.1212\/01.wnl.0000227187.52002.88","journal-title":"Neurology"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.freeradbiomed.2013.06.029","volume":"65","author":"E D'Amico","year":"2013","unstructured":"D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med 65:509\u2013527. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.06.029","journal-title":"Free Radic Biol Med"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.atherosclerosis.2014.09.034","volume":"237","author":"L Gomez Rosso","year":"2014","unstructured":"Gomez Rosso L et al (2014) Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation. Atherosclerosis 237:652\u2013660. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.034","journal-title":"Atherosclerosis"},{"key":"5_CR104","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/art.21976","volume":"54","author":"M McMahon","year":"2006","unstructured":"McMahon M et al (2006) Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54:2541\u20132549. https:\/\/doi.org\/10.1002\/art.21976","journal-title":"Arthritis Rheum"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2016-209683","volume":"76","author":"CK Smith","year":"2017","unstructured":"Smith CK et al (2017) Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity. Ann Rheum Dis 76:602\u2013611. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209683","journal-title":"Ann Rheum Dis"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1136\/annrheumdis-2012-202033","volume":"72","author":"A Vivekanandan-Giri","year":"2013","unstructured":"Vivekanandan-Giri A et al (2013) High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis. Ann Rheum Dis 72:1725\u20131731. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202033","journal-title":"Ann Rheum Dis"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","volume":"15","author":"K Gaal","year":"2016","unstructured":"Gaal K et al (2016) High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis 15:60. https:\/\/doi.org\/10.1186\/s12944-016-0229-0","journal-title":"Lipids Health Dis"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.fertnstert.2015.02.024","volume":"103","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril 103:1346\u20131354. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.02.024","journal-title":"Fertil Steril"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pathophys.2009.11.004","volume":"17","author":"AM Mohamadin","year":"2010","unstructured":"Mohamadin AM, Habib FA, Elahi TF (2010) Serum paraoxonase 1 activity and oxidant\/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology 17:189\u2013196. https:\/\/doi.org\/10.1016\/j.pathophys.2009.11.004","journal-title":"Pathophysiology"},{"key":"5_CR110","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.clnu.2016.02.003","volume":"36","author":"T Merono","year":"2017","unstructured":"Merono T et al (2017) Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemia. Clin Nutr 36:552\u2013558. https:\/\/doi.org\/10.1016\/j.clnu.2016.02.003","journal-title":"Clin Nutr"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2004.07.011","volume":"177","author":"V Zago","year":"2004","unstructured":"Zago V et al (2004) Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women. Atherosclerosis 177:203\u2013210. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.07.011","journal-title":"Atherosclerosis"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.jacl.2016.05.008","volume":"10","author":"B Hansel","year":"2016","unstructured":"Hansel B et al (2016) Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels. J Clin Lipidol 10:1172\u20131181. https:\/\/doi.org\/10.1016\/j.jacl.2016.05.008","journal-title":"J Clin Lipidol"},{"key":"5_CR113","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.amjcard.2010.12.014","volume":"107","author":"A Casella-Filho","year":"2011","unstructured":"Casella-Filho A et al (2011) Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. Am J Cardiol 107:1168\u20131172. https:\/\/doi.org\/10.1016\/j.amjcard.2010.12.014","journal-title":"Am J Cardiol"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.lfs.2005.12.015","volume":"78","author":"F Brites","year":"2006","unstructured":"Brites F et al (2006) HDL capacity to inhibit LDL oxidation in well-trained triathletes. Life Sci 78:3074\u20133081. https:\/\/doi.org\/10.1016\/j.lfs.2005.12.015","journal-title":"Life Sci"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/toxsci\/kfu076","volume":"140","author":"KH Park","year":"2014","unstructured":"Park KH, Shin DG, Cho KH (2014) Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation. Toxicol Sci 140:16\u201325. https:\/\/doi.org\/10.1093\/toxsci\/kfu076","journal-title":"Toxicol Sci"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1194\/jlr.P055491","volume":"56","author":"W Song","year":"2015","unstructured":"Song W et al (2015) The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients. J Lipid Res 56:682\u2013691. https:\/\/doi.org\/10.1194\/jlr.P055491","journal-title":"J Lipid Res"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.trsl.2009.01.007","volume":"153","author":"M Harangi","year":"2009","unstructured":"Harangi M et al (2009) Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity. Transl Res 153:190\u2013198. https:\/\/doi.org\/10.1016\/j.trsl.2009.01.007","journal-title":"Transl Res"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5551\/jat.5405","volume":"17","author":"S Yamashita","year":"2010","unstructured":"Yamashita S, Tsubakio-Yamamoto K, Ohama T, Nakagawa-Toyama Y, Nishida M (2010) Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions. J Atheroscler Thromb 17:436\u2013451. https:\/\/doi.org\/10.5551\/jat.5405","journal-title":"J Atheroscler Thromb"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1185\/030079907x226104","volume":"23","author":"SC Bergheanu","year":"2007","unstructured":"Bergheanu SC et al (2007) Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol. Curr Med Res Opin 23:2235\u20132240. https:\/\/doi.org\/10.1185\/030079907x226104","journal-title":"Curr Med Res Opin"},{"key":"5_CR120","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/s-0031-1296663","volume":"57","author":"D Muacevic-Katanec","year":"2007","unstructured":"Muacevic-Katanec D et al (2007) Clinical study on the effect of simvastatin on paraoxonase activity. Arzneimittelforschung 57:647\u2013653. https:\/\/doi.org\/10.1055\/s-0031-1296663","journal-title":"Arzneimittelforschung"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.phrs.2005.12.002","volume":"53","author":"I Tkac","year":"2006","unstructured":"Tkac I, Molcanyiova A, Javorsky M, Kozarova M (2006) Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity. Pharmacol Res 53:261\u2013264. https:\/\/doi.org\/10.1016\/j.phrs.2005.12.002","journal-title":"Pharmacol Res"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2007.03.001","volume":"196","author":"W Phuntuwate","year":"2008","unstructured":"Phuntuwate W et al (2008) Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels. Atherosclerosis 196:122\u2013128. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.03.001","journal-title":"Atherosclerosis"},{"issue":"116","key":"5_CR123","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1152\/japplphysiol.00969.2013","volume":"1985","author":"RE Kaplon","year":"2014","unstructured":"Kaplon RE, Gano LB, Seals DR (2014) Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol 1985(116):156\u2013163. https:\/\/doi.org\/10.1152\/japplphysiol.00969.2013","journal-title":"J Appl Physiol"},{"key":"5_CR124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MAJ.0b013e3182548c28","volume":"345","author":"S Hamoud","year":"2013","unstructured":"Hamoud S et al (2013) Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levels of high-density lipoprotein cholesterol. Am J Med Sci 345:195\u2013199. https:\/\/doi.org\/10.1097\/MAJ.0b013e3182548c28","journal-title":"Am J Med Sci"},{"key":"5_CR125","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/bcp.13198","volume":"83","author":"JR Batuca","year":"2017","unstructured":"Batuca JR et al (2017) Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial. Br J Clin Pharmacol 83:1002\u20131010. https:\/\/doi.org\/10.1111\/bcp.13198","journal-title":"Br J Clin Pharmacol"},{"key":"5_CR126","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1194\/jlr.M033555","volume":"54","author":"A Chattopadhyay","year":"2013","unstructured":"Chattopadhyay A et al (2013) A novel approach to oral apoA-I mimetic therapy. J Lipid Res 54:995\u20131010. https:\/\/doi.org\/10.1194\/jlr.M033555","journal-title":"J Lipid Res"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-2362.2006.01737.x","volume":"36","author":"KH Cho","year":"2006","unstructured":"Cho KH et al (2006) ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities. Eur J Clin Investig 36:875\u2013882. https:\/\/doi.org\/10.1111\/j.1365-2362.2006.01737.x","journal-title":"Eur J Clin Investig"},{"key":"5_CR128","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/hsz-2014-0188","volume":"396","author":"X Zhang","year":"2015","unstructured":"Zhang X, Wang L, Chen B (2015) Recombinant HDL (Milano) protects endotoxin-challenged rats from multiple organ injury and dysfunction. Biol Chem 396:53\u201360. https:\/\/doi.org\/10.1515\/hsz-2014-0188","journal-title":"Biol Chem"}],"container-title":["Advances in Experimental Medicine and Biology","HDL Metabolism and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-1592-5_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:03:19Z","timestamp":1652677399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-1592-5_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9789811915918","9789811915925"],"references-count":128,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-1592-5_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"17 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}